Director, Modality Platform Technologies
The Modality Platform Technologies (MPT) group specializes in the design, synthesis, and deployment of novel modalities, including oligonucleotides, targeted protein degraders, and antibody drug conjugates to accelerate drug discovery. The team brings together medicinal chemistry, synthetic organic chemistry, biology, biochemistry, and automation expertise to deliver ...
